Ernexa Therapeutics Inc.
Biopharmaceutical company developing cell therapies for cancer and autoimmune diseases.
ERNA | US
Overview
Corporate Details
- ISIN(s):
- US6294106066 (+1 more)
- LEI:
- Country:
- United States of America
- Address:
- 1035 CAMBRIDGE STREET, 2141 CAMBRIDGE
- Website:
- https://www.ernexatx.com/
- Sector:
- Manufacturing
Description
Ernexa Therapeutics Inc. is a biopharmaceutical company developing cell therapies for advanced cancer and autoimmune diseases. The company's core technology platform engineers induced pluripotent stem cells (iPSCs) and differentiates them into induced mesenchymal stem cells (iMSCs). These engineered iMSCs are designed as scalable, off-the-shelf treatments that leverage the natural ability of MSCs to home to sites of tumors or inflammation. Once at the target site, the cells deliver therapeutic payloads, such as cytokines, to modulate the immune system. The company's lead candidate, ERNA-101, is being developed for the treatment of ovarian cancer. Its pipeline also includes ERNA-201, a cell therapy designed to target inflammation in autoimmune diseases.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-11-07 17:30 |
10-Q
|
English | 1.3 MB | ||
| 2025-08-18 18:05 | English | 8.9 KB | |||
| 2025-08-13 18:31 |
10-Q
|
English | 1.2 MB | ||
| 2025-07-07 22:00 | English | 7.5 KB | |||
| 2025-07-07 18:39 |
8-K
|
English | 72.8 KB | ||
| 2025-06-20 02:15 | English | 5.4 KB | |||
| 2025-06-18 18:57 |
424B3
|
English | 36.0 KB | ||
| 2025-06-16 18:05 | English | 6.8 KB | |||
| 2025-06-16 11:36 | English | 58.0 KB | |||
| 2025-06-12 18:37 |
8-K
|
English | 73.5 KB | ||
| 2025-06-11 22:39 | English | 10.8 KB | |||
| 2025-06-11 22:34 |
OWNERSHIP DOCUMENT
|
English | 7.4 KB | ||
| 2025-06-11 18:35 |
S-8
|
English | 83.8 KB | ||
| 2025-06-11 18:30 |
S-3
|
English | 105.3 KB | ||
| 2025-06-09 18:30 |
8-K
|
English | 70.0 KB |
Automate Your Workflow. Get a real-time feed of all Ernexa Therapeutics Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Ernexa Therapeutics Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Ernexa Therapeutics Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
